http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104327027-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-10 |
| filingDate | 2014-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104327027-B |
| titleOfInvention | One class novel C aryl glucoside SGLT2 inhibitor |
| abstract | One class novel C aryl glucoside SGLT2 inhibitor, the present invention relates to the drug world related to diabetes, novel C aryl glucoside derivant shown in specifically related to a kind of logical formula (I), its preparation method, compositionss and their applications in hypoglycemic drug is prepared.There is described C aryl glucosides derivant extremely excellent rush glucose in urine to discharge effect and internal hypoglycemic activity, and therefrom filter out internal hypoglycemic activity even more excellent compound suitable with dapagliflozin, and which can be used for preventing or treats diabetes. |
| priorityDate | 2014-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 177.